Literature DB >> 16557617

An empirical investigation of psychopathy in a noninstitutionalized and noncriminal sample.

David DeMatteo1, Kirk Heilbrun, Geoffrey Marczyk.   

Abstract

This study examined the construct of psychopathy using the Psychopathy Checklist-Revised (PCL-R) in 54 participants from the general population. To obtain a sample of community participants with psychopathic characteristics, participants were recruited using advertisements for a "personality study" that incorporated the characteristics of psychopathy in a nonpejorative manner. The methodology successfully recruited community participants with moderately elevated PCL-R scores. Participants exhibited the personality features of psychopathy (Factor 1) to a greater extent than the behavioral features (Factor 2), which is consistent with the results obtained with the PCL-R normative samples. Roughly 40% of the sample reported no history of involvement with the criminal justice system, yet these participants exhibited moderately elevated PCL-R scores. Moreover, a sizeable portion of the noncriminal participants reported a substantial history of violent behavior. Comparisons of PCL-R scores between participants with and without a criminal history suggest that these two groups differ in ways unrelated to criminal justice system involvement. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16557617     DOI: 10.1002/bsl.667

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  9 in total

1.  Subcomponents of psychopathy have opposing correlations with punishment judgments.

Authors:  Jana Schaich Borg; Rachel E Kahn; Walter Sinnott-Armstrong; Robert Kurzban; Paul H Robinson; Kent A Kiehl
Journal:  J Pers Soc Psychol       Date:  2013-07-08

2.  Factor structure of the Psychopathic Personality Inventory (PPI): findings from a large incarcerated sample.

Authors:  Craig S Neumann; Melanie B Malterer; Joseph P Newman
Journal:  Psychol Assess       Date:  2008-06

Review 3.  The Development of Severe and Chronic Violence Among Youth: The Role of Psychopathic Traits and Reward Processing.

Authors:  Dennis E Reidy; Elizabeth Krusemark; David S Kosson; Megan C Kearns; Joanne Smith-Darden; Kent A Kiehl
Journal:  Child Psychiatry Hum Dev       Date:  2017-12

4.  Reducing psychopathic violence: A review of the treatment literature.

Authors:  Dennis E Reidy; Megan C Kearns; Sarah DeGue
Journal:  Aggress Violent Behav       Date:  2013 Sep-Oct

5.  Improving characterization of psychopathy within the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), alternative model for personality disorders: Creation and validation of Personality Inventory for DSM-5 Triarchic scales.

Authors:  Laura E Drislane; Martin Sellbom; Sarah J Brislin; Casey M Strickland; Elliott Christian; Dustin B Wygant; Robert F Krueger; Christopher J Patrick
Journal:  Personal Disord       Date:  2019-07-01

6.  Psychopathy Traits and Violent Assault Among Men With and Without History of Arrest.

Authors:  Dennis E Reidy; Scott O Lilienfeld; Danielle S Berke; Brittany Gentile; Amos Zeichner
Journal:  J Interpers Violence       Date:  2016-07-25

7.  Distinct variants of extreme psychopathic individuals in society at large: evidence from a population-based sample.

Authors:  Laura E Drislane; Christopher J Patrick; Andre Sourander; Lauri Sillanmäki; Steven H Aggen; Henrik Elonheimo; Kai Parkkola; Petteri Multimäki; Kenneth S Kendler
Journal:  Personal Disord       Date:  2014-02-10

8.  Psychopathic traits associated with abnormal hemodynamic activity in salience and default mode networks during auditory oddball task.

Authors:  Nathaniel E Anderson; J Michael Maurer; Vaughn R Steele; Kent A Kiehl
Journal:  Cogn Affect Behav Neurosci       Date:  2018-06       Impact factor: 3.282

9.  Dissociable Effects of Psychopathic Traits on Executive Functioning: Insights From the Triarchic Model.

Authors:  Rita Pasion; Ana R Cruz; Fernando Barbosa
Journal:  Front Psychol       Date:  2018-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.